![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 75.00 | 73.00 | 77.00 | 75.00 | 75.00 | 75.00 | 15,165 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -6.93 | 49.49M |
RNS Number : 8702C Celsis International PLC 05 September 2008 For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer Celsis International of existing shares to which voting rights are Plc attached: 2. Reason for notification (yes/no) X An acquisition or disposal of voting rights An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):______________ 3. Full name of person(s) Barclays PLC subject to notification obligation: Barclays Global 4. Full name of shareholder(s) Investors Ltd (if different from 3): Barclays Life Assurance Co Ltd Barclays Stockbrokers Ltd 03-Sep-08 5. Date of transaction (and date on which the threshold is crossed or reached if different): 04-Sep-08 6. Date on which issuer notified: 7% to 6% 7. Threshold(s) that is/are crossed or reached: 8: Notified Details A: Voting rights attached to shares Class/type of shares Situation previous to the triggering Resulting situation after the triggering transaction If possible use ISIN transaction code Number of shares Number of voting Number of shares Number of voting Percentage of voting rights rights rights Direct Indirect Direct Indirect 1,619,344 1,619,344 1,394,164 0 1,394,164 0.00 6.36 GB00B0CD5F69 B: Financial Instruments Resulting situation after the triggering transaction Type of financial instrument Expiration date Exercise/ conversion No. of voting rights Percentage of voting period/date that may be acquired rights (if the instrument exercised/converted) Total (A+B) Number of voting rights Percentage of voting rights 1,394,164 6.36 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: Barclays Global Investors Ltd Barclays Life Assurance Co Ltd Barclays Stockbrokers Ltd Proxy Voting: 10. Name of proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14 Contact name: Geoff Smith 15. Contact telephone number: 020 7116 2913 For notes on how to complete form TR-1 please see the FSA website. This information is provided by RNS The company news service from the London Stock Exchange END HOLUVSORWKRKRAR
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions